References

  1. Pholtex Mucus 200 effervescent tablets professional information.
  2. Helms S, Miller A. Natural treatment of chronic rhinosinusitis. Altern Med Rev. 2006;11(3):196-207.
  3. Macchi A, Terranova P, Castelnuovo P. Recurrent acute rhinosinusitis: a single blind clinical study of N-acetylcysteine vs ambroxol associated to corticosteroid therapy. Int J Immunopathol Pharmacol. 2012;25(1):207-17. doi: 10.1177/039463201202500123.
  4. MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); [updated 2022 March 25]. Acetylcysteine Oral Inhalation; [revised 2017 March 15; cited 2022 April 19]; [about 4 p.]. Available from: https://medlineplus.gov/druginfo/meds/a615021.html.
  5. Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants (Basel). 2021;10(6):967. doi: 10.3390/antiox10060967.
  6. South African Medicine Price Registry. Available at: http://www.mpr.gov.za/PublishedDocuments.aspx#DocCatId=21 [Cited 13 April 2022].
  7. Ipci K, Öktemer T, Birdane L, Altintoprak N, Muluk NB, Passali D, et al. Effervescent tablets: a safe and practical delivery system for drug administration. ENT Updates. 2016;6(1):46–50. doi:10.2399/jmu.2016001009.
  8. Schwalfenberg GK. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks). J Nutr Metab. 2021:9949453. doi: 10.1155/2021/9949453.
  9. Premier Health. Barometers of Health (2018) at https://www.premierhealth.com/your-health/articles/women-wisdom-wellness-/mucus-and-phlegm-barometers-of-your-health (website accessed 14 March 2021).
  10. What is Mucus? (2019) at https://www.medicinenet.com/what_is_mucus/article.htm (website accessed 14 March 2021).
  11. Banerjee S and McCormack S. Acetylcysteine for Patients Requiring Mucous Secretion Clearance: A Review of Clinical Effectiveness and Safety. National Library of Medicine. NCBI. https://www.ncbi.nlm.nih.gov/books/NBK546019/ (website accessed 19 May 2022).
  12. Mayo Clinic. Acute Sinusitis_https://www.mayoclinic.org/diseases-conditions/acute-sinusitis/symptoms-causes/syc-20351671 (website accessed 19 May 2022).
  13. Truter I. Cough. Evidence Based Pharmacy Practice. SA Pharm J 2007;74(4):20-27.
  14. Cough treatment. Specialist Forum 2017;17(6): 28-30
  15. Van Schoor J. An approach to recommending cough mixtures in pharmacy. S Afr Pharm J 2012;79(6):30-33.
  16. De Blasio F, Virchow JC, Polverino M, et al. Cough management: a practical approach. Cough 2011;7(1):7.
  17. Mayo Clinic. Healthy sinuses. https://www.mayoclinic.org/diseases-conditions/nonallergic-rhinitis/multimedia/img-20453026 (website accessed 19 May 2022).
  18. NHS Inform. Sinusitis. https://www.nhsinform.scot/illnesses-and-conditions/ears-nose-and-throat/sinusitis (website accessed 19 May 2022).
  19. Picton G. Tips help manage pesky sinus symptoms.[Online 22 March 2012]. Available at: https://www.bcm.edu/news/tips-help-manage-pesky-sinus-symptoms. [Cited 6 May 2022].

Scheduling status: S1 Proprietary name (and dosage form): Pholtex Mucus 200. Composition: Each effervescent tablet contains 200mg N-Acetylcysteine. Registration number: 43/10.2.2/0512. Name and business address of applicant: iNova Pharmaceuticals (Pty) Ltd. Co. Reg. No. 1952/001640/07. 15e Riley Road, Bedfordview. Tel: 011 087 0000. www.inovapharma.co.za. For full prescribing information, refer to the package insert as approved by the SAHPRA (South African Health Products Regulatory Authority). Further information is available on request from iNova Pharmaceuticals.IN4632/22